439 related articles for article (PubMed ID: 22914685)
1. Biomarkers in native and transplant kidneys: opportunities to improve prediction of outcomes in chronic kidney disease.
De Serres SA; Varghese JC; Levin A
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):619-27. PubMed ID: 22914685
[TBL] [Abstract][Full Text] [Related]
2. Chronic kidney disease 10 years on: what have we learned?
Taal MW
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):607-11. PubMed ID: 23010759
[TBL] [Abstract][Full Text] [Related]
3. [Chronic kidney disease what is it?].
Joly D
Rev Prat; 2012 Jan; 62(1):34-7. PubMed ID: 22335064
[TBL] [Abstract][Full Text] [Related]
4. Risk prediction in chronic kidney disease: pitfalls and caveats.
Rigatto C; Sood MM; Tangri N
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):612-8. PubMed ID: 23042027
[TBL] [Abstract][Full Text] [Related]
5. Risk Prediction for Early CKD in Type 2 Diabetes.
Dunkler D; Gao P; Lee SF; Heinze G; Clase CM; Tobe S; Teo KK; Gerstein H; Mann JF; Oberbauer R;
Clin J Am Soc Nephrol; 2015 Aug; 10(8):1371-9. PubMed ID: 26175542
[TBL] [Abstract][Full Text] [Related]
6. Estimated glomerular filtration rate and albuminuria: diagnosis, staging, and prognosis.
Komenda P; Rigatto C; Tangri N
Curr Opin Nephrol Hypertens; 2014 May; 23(3):251-7. PubMed ID: 24675138
[TBL] [Abstract][Full Text] [Related]
7. [Epidemiology of chronic kidney disease].
Noël D; Landais P
Rev Prat; 2012 Jan; 62(1):38-42. PubMed ID: 22335065
[TBL] [Abstract][Full Text] [Related]
8. Predicting progression to chronic kidney disease after recovery from acute kidney injury.
Heung M; Chawla LS
Curr Opin Nephrol Hypertens; 2012 Nov; 21(6):628-34. PubMed ID: 23010757
[TBL] [Abstract][Full Text] [Related]
9. Renal disease in adult Nigerians with sickle cell anemia: a report of prevalence, clinical features and risk factors.
Bolarinwa RA; Akinlade KS; Kuti MA; Olawale OO; Akinola NO
Saudi J Kidney Dis Transpl; 2012 Jan; 23(1):171-5. PubMed ID: 22237246
[TBL] [Abstract][Full Text] [Related]
10. Is all chronic kidney disease created equal?
Lane BR; Demirjian S; Derweesh IH; Riedinger CB; Fergany AF; Campbell SC
Curr Opin Urol; 2014 Mar; 24(2):127-34. PubMed ID: 24451089
[TBL] [Abstract][Full Text] [Related]
11. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of chronic kidney disease among older adults: a focus on the oldest old.
Bowling CB; Muntner P
J Gerontol A Biol Sci Med Sci; 2012 Dec; 67(12):1379-86. PubMed ID: 22960475
[TBL] [Abstract][Full Text] [Related]
13. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
[TBL] [Abstract][Full Text] [Related]
14. Hypertension in moderate-to-severe nondiabetic CKD patients.
Segura J; Ruilope LM
Adv Chronic Kidney Dis; 2011 Jan; 18(1):23-7. PubMed ID: 21224027
[TBL] [Abstract][Full Text] [Related]
15. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.
Mohsen A; Brown R; Hoefield R; Kalra PA; O'Donoghue D; Middleton R; New D
J Nephrol; 2012; 25(3):384-93. PubMed ID: 22241634
[TBL] [Abstract][Full Text] [Related]
16. Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD).
Formentini I; Bobadilla M; Haefliger C; Hartmann G; Loghman-Adham M; Mizrahi J; Pomposiello S; Prunotto M; Meier M
Nephrol Dial Transplant; 2012 Oct; 27 Suppl 3():iii81-8. PubMed ID: 22734108
[TBL] [Abstract][Full Text] [Related]
17. FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
Alderson HV; Ritchie JP; Middleton R; Larsson A; Larsson TE; Kalra PA
Nephrology (Carlton); 2016 Jul; 21(7):566-73. PubMed ID: 27334353
[TBL] [Abstract][Full Text] [Related]
18. Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.
Malyszko J; Bachorzewska-Gajewska H; Sitniewska E; Malyszko JS; Poniatowski B; Dobrzycki S
Ren Fail; 2008; 30(6):625-8. PubMed ID: 18661413
[TBL] [Abstract][Full Text] [Related]
19. Role of neutrophil/lymphocyte ratio in prediction of disease progression in patients with stage-4 chronic kidney disease.
Kocyigit I; Eroglu E; Unal A; Sipahioglu MH; Tokgoz B; Oymak O; Utas C
J Nephrol; 2013; 26(2):358-65. PubMed ID: 22573523
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular and renal outcome in subjects with K/DOQI stage 1-3 chronic kidney disease: the importance of urinary albumin excretion.
Brantsma AH; Bakker SJ; Hillege HL; de Zeeuw D; de Jong PE; Gansevoort RT;
Nephrol Dial Transplant; 2008 Dec; 23(12):3851-8. PubMed ID: 18641082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
